CLINICAL_TRIALS
trial_result
· 2013-03-22
Clinical Trial Update: Long-term Safety of Alogliptin in Patients With Type 2 Diabetes Mellitus [Phase 3]
Summary
This document reports the long-term safety results from a Phase 3 trial of alogliptin in patients with type 2 diabetes mellitus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2013-03-22